טוען...
Discovery of small molecule inhibitors of the HSP90-calcineurin-NFAT pathway against glioblastoma
Glioblastoma (GBM) is among the most common and malignant types of primary brain tumors in adult with a dismal prognosis. Although alkylating agents such as temozolomide are widely applied as the first-line treatment for GBM, they often cause chemoresistance and remain ineffective with recurrent GBM...
שמור ב:
| הוצא לאור ב: | Cell Chem Biol |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6430684/ https://ncbi.nlm.nih.gov/pubmed/30639261 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.chembiol.2018.11.009 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|